Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 2013, 278392

Pharmacological Intervention of Nicotine Dependence

Affiliations
Review

Pharmacological Intervention of Nicotine Dependence

Raka Jain et al. Biomed Res Int.

Abstract

Nicotine dependence is a major cause of mortality and morbidity all over the world. Various medications have been tried to treat nicotine dependence including nicotine replacement therapy, bupropion, and varenicline. A newer venture to nicotine dependence treatment is a nicotine vaccine which is yet to get footsteps in common practice. The present review assimilates various pharmacotherapeutic measures to address nicotine dependence. However, it is to be noted that psychological interventions, when combined with pharmacotherapy, offer the greatest benefits to the patients.

Similar articles

See all similar articles

Cited by 8 PubMed Central articles

See all "Cited by" articles

References

    1. World Health Organization. WHO Report on the Global Tobacco Epidemic. Geneva, Switzerland: World Health Organization; 2009.
    1. Prevalence of tobacco use. WHO India, http://www.cccindia.co/corecentre/Database/Docs/DocFiles/Tobacco_03_2.pdf.
    1. WHO global report: mortality attributable to tobacco. 2012, http://www.who.int/tobacco/publications/surveillance/rep_mortality_attibutable/en/index.html.
    1. Fiore MC, Jaen CR, Baker TB, et al. Clinical Practice Guideline: Treating Tobacco Use and Dependence. Rockville, Md, USA: U.S. Department of Health and Human Services; 2000. (Tobacco Use and Dependence Guideline Panel). http://www.ahrq.gov/path/tobacco.htm#Clinic.
    1. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Rockville, Md, USA: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2004.

MeSH terms

Feedback